Monkeypox in the United States and Around the World: Current Situation

Introduction

Monkeypox — now commonly known as mpox — continues to circulate across different regions of the world, even though the global outbreak that started in 2022 has slowed down. As of 2025, health experts are monitoring two major strains of the virus, watching for new patterns of transmission, and tracking how the situation is evolving in the United States and internationally. This blog provides a clear, link-free overview of the current status of mpox both domestically and globally.



What Is Monkeypox (Mpox)?

Mpox is a viral disease from the same family as smallpox, but generally less severe. There are two main clades (types) of the virus:

  • Clade I – historically found in Central and Eastern Africa and considered more severe.
  • Clade II – responsible for the widespread global outbreak beginning in 2022, and typically less severe than Clade I.

How It Spreads

The virus spreads through:

  • Close physical or sexual contact
  • Contact with skin lesions or bodily fluids
  • Contaminated clothing, bedding, or surfaces

Common Symptoms

  • Fever
  • Rash or skin lesions
  • Swollen lymph nodes
  • Fatigue
  • Body aches

Current Situation in the United States

1. Local Transmission of Clade I

In recent months, the U.S. has detected cases of Clade I mpox, including individuals who had no travel history, suggesting local transmission. This is notable because Clade I cases were previously rare outside Africa.

2. Continued Circulation of Clade II

Clade II, which caused the major global outbreak in 2022–2023, continues to circulate in the U.S., but at much lower levels. Most cases appear in clusters, often linked to close or intimate contact.

3. Travel-Related Infections

Some recent U.S. cases have been linked to travel from West African countries, where ongoing mpox outbreaks continue. Travelers may unintentionally bring the virus into the country, where it can lead to small chains of local transmission.

4. Vaccination & Immunity

  • Two vaccine doses provide strong protection.
  • People previously infected also develop immunity.
  • Boosters are not routinely recommended at this time.
  • Access to vaccines remains good in the U.S., especially for high-risk groups.

Global Mpox Situation

1. Clade I Activity in Africa

Central and Eastern Africa continue to report Clade I outbreaks, especially in areas with:

Sub-types of Clade I, such as Ib, show some capacity for human-to-human transmission.

2. Clade II’s Worldwide Presence

Since 2022, Clade II has spread globally, with tens of thousands of cases reported across nearly every continent. Although much lower now than at the outbreak’s peak, Clade II continues to circulate at a low but steady rate in many countries.

3. Regional Trends

  • West Africa: New clusters of Clade II continue to appear.
  • Eastern Mediterranean & Europe: Small spikes have been noted compared to previous months.
  • Americas: Most countries report small, controlled outbreaks.

4. Challenges in Africa

Many African regions still face:

  • Limited vaccine supply
  • Under-resourced testing and surveillance
  • High exposure to wildlife
    These challenges contribute to persistent outbreaks and increase the risk of spread beyond the region.

Why This Matters

1. Potential for Re-Emergence

Even when cases decline, mpox can resurface through:

  • Travel
  • Close-contact transmission
  • Undetected community spread

2. Importance of Vaccination

Vaccines remain a powerful tool in reducing transmission, especially among high-risk populations.

3. Avoiding Stigma

Accurate information helps prevent discrimination. Mpox can affect anyone through close contact — misinformation only harms public health efforts.

4. Global Health Equity

Outbreaks grow when:

  • Countries lack proper vaccines
  • Surveillance is weak
  • Health systems are underfunded

Supporting global response efforts is essential to preventing the disease from spreading internationally.

What You Can Do

  • Stay informed about symptoms and prevention.
  • Avoid close contact with anyone who has a new rash or unexplained lesions.
  • Consider vaccination if you belong to a high-risk group.
  • Practice hygiene, such as hand washing and safe handling of personal items.
  • Support awareness without spreading fear or stigma.

Conclusion

Monkeypox remains a global health issue, even though many countries have seen declining cases. The presence of both Clade I and Clade II, especially with local transmission appearing in new areas, shows that continued caution and public health surveillance are essential. With vaccines, awareness, and coordinated global efforts, mpox can be effectively controlled — but the world must remain vigilant.